Nurse-Led Programs Improve Outcomes in Rheumatoid ArthritisMedscapeMADRID, Spain — When nurses screen patients with rheumatoid arthritis (RA) for comorbidities and teach them the skills to self-assess disease activity, outcomes improve, according to 2 analyses of data from the COMEDRA study. "…
18 June 2013 | 9:10 pm
Toronto NewsFIXRheumatoid Arthritis Treatment May Not Work As Well for Heavier PatientsU.S. News & World ReportTUESDAY, June 18 (HealthDay News) — Overweight and obese people with rheumatoid arthritis are less likely to go into remission in the early stages of the disease and require much more drug…
18 June 2013 | 4:07 pm
Triple Therapy as Good as Biologics for Rheumatoid ArthritisMedscapeMADRID, Spain — A triple regimen of older drugs is as effective as biologics for patients with active rheumatoid arthritis (RA) who fail to respond to methotrexate, according to the results of a large clinical trial. The triple th…
17 June 2013 | 8:33 pm
Drug Discontinuations Rampant in Rheumatoid ArthritisMedscape"Despite the availability of multiple therapies for rheumatoid arthritis in the United States, there is a high rate of discontinuation or change in therapy. We think this may be because patients have high expectations, but none of the…
15 June 2013 | 11:34 am
Who Does Better After Joint Replacement Surgery: Rheumatoid Arthritis or …About – News & IssuesHave you ever wondered how well rheumatoid arthritis patients do after joint replacement surgery compared to osteoarthritis patients? Researchers from the Hospital for Special Surgery (HSS) have the answ…
14 June 2013 | 10:52 pm
Many Stop Taking Rheumatoid Arthritis Meds Too Soon: StudyU.S. News & World ReportFRIDAY, June 14 (HealthDay News) — About half of rheumatoid arthritis patients stopped taking their medications within two years after they started them, a new study finds. Rheumatoid arthritis affects about one in 10…
14 June 2013 | 8:10 pm
Novel biomarkers improve diagnosis in rheumatoid arthritisEurekAlert (press release)Madrid, Spain, 12 June 2013: Data presented at EULAR 2013, the Annual Congress of the European League Against Rheumatism, show that novel antibody biomarkers could significantly improve diagnosis in rheumatoid arthri…
14 June 2013 | 9:38 am
iStockAnalystLilly's oral rheumatoid arthritis blockbuster contender champions 1-year studyFierceBiotechEfficacy results for an experimental rheumatoid arthritis drug in development by Eli Lilly ($LLY) and Incyte ($INCY) held up well as patients in a Phase IIb trial were tracked over the course…
13 June 2013 | 1:16 pm
Childbirth increases risk of ACPA-negative rheumatoid arthritisEurekAlert (press release)Madrid, Spain, 13 June 2013: Epidemiological data presented today at EULAR 2013, the Annual Congress of the European League Against Rheumatism, demonstrate that pregnancy carried to childbirth (parity) increases…
13 June 2013 | 7:48 am
Standard RA Therapy as Good as Costlier Newcomer?WebMDTUESDAY, June 11 (HealthDay News) — Newer, costlier treatment for rheumatoid arthritis appears no better than an older, less-expensive regimen for people who don't respond to the first-line drug methotrexate, a new study suggests. "Newe…
12 June 2013 | 3:47 pm
